These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4266033)

  • 21. Drug-induced Parkinson-like syndrome.
    Va Med Mon (1918); 1968 Dec; 95(12):746-50 passim. PubMed ID: 5725399
    [No Abstract]   [Full Text] [Related]  

  • 22. Neurophysiological substrates of the pharmacological criteria for neuroleptics.
    Stille G
    Mod Probl Pharmacopsychiatry; 1970; 5():56-60. PubMed ID: 5527169
    [No Abstract]   [Full Text] [Related]  

  • 23. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R
    Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract]   [Full Text] [Related]  

  • 24. A dopaminergic-cholinergic mechanism in production of psychotic symptoms.
    Friedhoff AJ; Alpert M
    Biol Psychiatry; 1973 Apr; 6(2):165-9. PubMed ID: 4709131
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biogenic amines and schizophrenia].
    Schöpf J
    Schweiz Med Wochenschr; 1975 Sep; 105(38):1201-9. PubMed ID: 1061994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug-induced Parkinson's syndrome with cycle-dependent hyperkineses following intake of the contraceptive "Gestakliman"].
    Jörg J
    Nervenarzt; 1971 Jun; 42(6):325-9. PubMed ID: 4397217
    [No Abstract]   [Full Text] [Related]  

  • 27. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J; Schmidt WJ
    Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of basal ganglia in rhythmic movement.
    Freund HJ; Hefter H
    Adv Neurol; 1993; 60():88-92. PubMed ID: 8420222
    [No Abstract]   [Full Text] [Related]  

  • 29. [Possible participation of limbic structures of the forebrain in the mechanism of the antipsychotic effect of neuroleptic preparations in schizophrenia (review)].
    Aksent'ev SB; Mokhovikov AN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1254-60. PubMed ID: 6137921
    [No Abstract]   [Full Text] [Related]  

  • 30. Dopamine and extrapyramidal motor function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():390-415. PubMed ID: 4561070
    [No Abstract]   [Full Text] [Related]  

  • 31. Prolactin secretion as an index of brain dopaminergic function.
    Thorner MO; Login IS
    Adv Biochem Psychopharmacol; 1981; 28():503-20. PubMed ID: 6452035
    [No Abstract]   [Full Text] [Related]  

  • 32. Pathophysiology of parkinsonian motor abnormalities.
    Wichmann T; DeLong MR
    Adv Neurol; 1993; 60():53-61. PubMed ID: 8420185
    [No Abstract]   [Full Text] [Related]  

  • 33. Basal ganglia oscillations and pathophysiology of movement disorders.
    Rivlin-Etzion M; Marmor O; Heimer G; Raz A; Nini A; Bergman H
    Curr Opin Neurobiol; 2006 Dec; 16(6):629-37. PubMed ID: 17084615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipsychotic drug actions: a clue to the neuropathology of schizophrenia?
    Matthysse S
    Fed Proc; 1973 Feb; 32(2):200-5. PubMed ID: 4348519
    [No Abstract]   [Full Text] [Related]  

  • 35. Proceedings: Differentiation between neuroleptic antipsychotic properties and side effects by subgroups of dopaminergic neurons.
    Bunney BS; Aghajanian GK
    Psychopharmacol Bull; 1974 Oct; 10(4):17-8. PubMed ID: 4473793
    [No Abstract]   [Full Text] [Related]  

  • 36. Spatial and temporal profile of haloperidol-induced immediate-early gene expression and phosphoCREB binding in the dorsal and ventral striatum of amphetamine-sensitized rats.
    Hsieh HC; Li HY; Lin MY; Chiou YF; Lin SY; Wong CH; Chen JC
    Synapse; 2002 Sep; 45(4):230-44. PubMed ID: 12125044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The current model of basal ganglia organization under scrutiny.
    Parent A; Cicchetti F
    Mov Disord; 1998 Mar; 13(2):199-202. PubMed ID: 9539330
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathophysiology of drug-induced dyskinesias.
    Korczyn AD
    Neuropharmacology; 1972 Sep; 11(5):601-7. PubMed ID: 4275111
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopamine receptor site sensitivity in hyperthyroid and hypothyroid guinea pigs.
    Klawans HL; Goetz C; Weiner WJ
    Adv Neurol; 1974; 5():495-500. PubMed ID: 4474797
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuroleptic and non-neuroleptic catalepsy.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1973 May; 23(5):674-83. PubMed ID: 4740210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.